Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TXNRD1 | Q16881 | 3/20 | 1.00 |
| ▸ | AURKA | O14965 | 2/20 | 1.00 |
| ▸ | CDC25B | P30305 | 2/20 | 1.00 |
| ▸ | AURKB | Q96GD4 | 2/20 | 1.00 |
| ▸ | TXNRD3 | Q86VQ6 | 2/20 | 1.00 |
| ▸ | TXNRD2 | Q9NNW7 | 2/20 | 1.00 |
| ▸ | CYP1A1 | P04798 | 1/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 1/20 | 1.00 |
| ▸ | COPS5 | Q92905 | 1/20 | 1.00 |
| ▸ | MAPT | P10636 | 6/20 | 0.58 |
| ▸ | MEN1 | O00255 | 5/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 5/20 | 0.58 |
| ▸ | HPGD | P15428 | 5/20 | 0.58 |
| ▸ | USP2 | O75604 | 4/20 | 0.58 |
| ▸ | THRB | P10828 | 4/20 | 0.58 |
| ▸ | ALOX15 | P16050 | 4/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.58 |
| ▸ | TP53 | P04637 | 4/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Naphthazalin SCHEMBL29353283 | 1.00 | TXNRD1 (1.00) | TXNRD1AURKACDC25BAURKBTXNRD3 | |
| Naphthazalin SCHEMBL27700955 | 1.00 | TXNRD1 (1.00) | TXNRD1AURKACDC25BAURKBTXNRD3 | |
| Naphthazalin SCHEMBL6122890 | 0.97 | TXNRD1 (0.94) | TXNRD1AURKACDC25BAURKBTXNRD3 | |
| Naphthazalin SCHEMBL21403377 | 0.97 | TXNRD1 (0.94) | TXNRD1AURKACDC25BAURKBTXNRD3 | |
| SCHEMBL10401666 | 0.87 | TXNRD1 (0.76) | TXNRD1AURKACDC25BAURKBTXNRD3 | |
| SCHEMBL8996435 | 0.85 | TXNRD1 (0.73) | TXNRD1AURKACDC25BAURKBTXNRD3 | |
| SCHEMBL2182692 | 0.85 | AURKA (0.73) | TXNRD1AURKACDC25BAURKBTXNRD3 | |
| SCHEMBL17265619 | 0.85 | AURKA (0.73) | TXNRD1AURKACDC25BAURKBTXNRD3 | |
| SCHEMBL28091853 | 0.84 | TXNRD1 (0.71) | TXNRD1AURKACDC25BAURKBTXNRD3 | |
| SCHEMBL31157962 | 0.84 | TXNRD1 (0.71) | TXNRD1AURKACDC25BAURKBTXNRD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1250 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260125721-A1 | ACIDOPHILIC FUSARIUM OXYSPORUM STRAINS, METHODS OF THEIR PRODUCTION AND METHODS OF THEIR USE | THE FYNDER GROUP, INC. | 2026-05-07 | — | — | US | claimed |
| EP-4680027-A1 | A METHOD FOR IMPARTING ANTIMICROBIAL PROPERTIES TO A SYNTHETIC SUBSTRATE | Biocompatibility Innovation Srl (IT) | 2026-01-21 | — | — | EP | claimed |
| EP-3788093-B1 | SQUARIC ACID-BASED POLYMERS, THEIR MANUFACTURING PROCESSES AND THEIR USES | HYDRO QUEBEC (CA) | 2025-12-10 | — | — | EP | claimed |
| CN-120114610-A | Copper ion complex based on protein template and preparation method and application thereof | 中国药科大学 | 2025-06-10 | — | — | CN | claimed |
| US-20250129207-A1 | SQUARIC ACID-BASED POLYMERS, THEIR MANUFACTURING PROCESSES AND THEIR USES | HYDRO-QUéBEC (CA) | 2025-04-24 | — | — | US | claimed |
| US-12111315-B2 | Smart glass slide for microarrays | ROBERT BOSCH GMBH (DE) | 2024-10-08 | — | — | US | claimed |
| US-20240315965-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2024-09-26 | — | — | US | claimed |
| WO-2024189407-A1 | A METHOD FOR IMPARTING ANTIMICROBIAL PROPERTIES TO A SYNTHETIC SUBSTRATE | Biocompatibility Innovation S.r.l. (IT) | 2024-09-19 | — | — | WO | claimed |
| EP-3280402-B1 | TOLAN COMPOUNDS FOR PROMOTING WOUND HEALING | BIOMENDICS LLC (US) | 2024-06-05 | — | — | EP | claimed |
| CN-118022683-A | Preparation method of adsorbent, MAA wastewater treatment device and process | 万华化学集团股份有限公司 | 2024-05-14 | — | — | CN | claimed |
| US-4832943-A | HYDROXYQUINONE, MESOTARTARALDEHYDE | L'OREAL (FR) | 1989-05-23 | — | — | US | claimed |
| EP-0109677-B1 | DIPLATINUM COMPLEX, METHOD FOR PREPARING AND AN ANTI-CANCER AGENT CONTAINING SAME | Research Corporation (US) | 1987-07-22 | — | — | EP | claimed |
| US-4650885-A | Process for preparing derivatives of naphthazarin | NIPPON OIL CO., LTD. (JP) | 1987-03-17 | — | — | US | claimed |
| EP-0200219-A2 | Process for preparing derivatives of naphthazarin | NIPPON OIL CO. LTD. (JP) | 1986-11-05 | — | — | EP | claimed |
| US-4588831-A | ANTITUMOR AGENTS | NATEC (DE) | 1986-05-13 | — | — | US | claimed |
| EP-0144809-A2 | Complex platinum compounds of substituted 5,8-dihydroxy-1,4 naphtoquinones, process for their preparation and their use | NATEC Institut für naturwissenschaftlich- technische Dienste GmbH (DE) | 1985-06-19 | — | — | EP | claimed |
| US-4425404-A | MULTILAYER, PROTECTIVE COATINGS | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 1984-01-10 | — | — | US | claimed |
| US-4078070-A | DIHYDROPYRAN-3-CARBOXYLIC ACID ANILIDE WITH A BENZIMIDAZOLE-2-CARBAMATE | HOECHST AKTIENGESELLSCHAFT (DT) | 1978-03-07 | — | — | US | claimed |
| US-4041164-A | ALUMINUM CHELATES OF A HYDROXY-QUINONE | HOECHST AKTIENGESELLSCHAFT (DT) | 1977-08-09 | — | — | US | claimed |
| US-4030882-A | Solvent dyeing compositions and a method of dyeing polyester fibers therewith | EASTMAN KODAK COMPANY (US) | 1977-06-21 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260125721-A1 | ACIDOPHILIC FUSARIUM OXYSPORUM STRAINS, METHODS OF THEIR PRODUCTION AND METHODS OF THEIR USE | TKT, SPOUT1, TALDO1 | TXNRD1 182/4885AURKA 2442/4885CDC25B 3264/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.